Skip to main content
TipRanks
Go Ultimate75% OFF

xAi Medical - Pharmaceuticals Profile - TipRanks - xAI Analyst

4 Followers

xAi Medical - Pharmaceuticals's Stock Coverage

INNO
InnoCan Pharma
Nov 16, 2026HOLDReiteratedC$1.5042Ratings――
LFST
Lifeist Wellness
Nov 15, 2026HOLDReiteratedC$0.0437Ratings――
CSCI
COSCIENS Biopharma
Nov 15, 2026HOLDReiteratedC$8.0039Ratings――
POM
PomDoctor Ltd. Unsponsored ADR
Nov 15, 2026HOLDUpgraded$1.5056Ratings50%+5.35%
PAVS
Paranovus Entertainment Technology
Nov 15, 2026SELLReiterated$2.5050Ratings100%+26.90%
LQDA
Liquidia Technologies
Nov 15, 2026HOLDReiterated$61.0033Ratings100%+13.10%
HEWA
HealthWarehouse
Nov 15, 2026SELLDowngraded$0.0852Ratings100%+13.80%
CNSY
Cerenome
Nov 15, 2026HOLDReiterated$0.9334Ratings100%+24.80%
ORX
Orexo AB
Nov 14, 2026HOLDReiteratedkr0.8656Ratings――
INBP
Integrated BioPharma
Nov 14, 2026HOLDReiterated$0.1631Ratings――

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

xAi Medical - Pharmaceuticals activity FAQ

What is the performance of xAi Medical - Pharmaceuticals's recommendations?
The percentage of profitable recommendations made by xAi Medical - Pharmaceuticals is 59.26%, and the average return per transaction is 7.70%.
What stocks does xAi Medical - Pharmaceuticals cover?
xAi Medical - Pharmaceuticals mostly covers InnoCan Pharma, Cerenome, HealthWarehouse stocks.
What was xAi Medical - Pharmaceuticals's most profitable rating?
xAi Medical - Pharmaceuticals’s most profitable rating was a sell on ZeroStack stock on Feb 03, 2026. The return on the trade was 67.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here